Status:
COMPLETED
Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases
Lead Sponsor:
San Carlo Public Hospital, Potenza, Italy
Conditions:
Autoimmune Diseases
Infertility
Eligibility:
FEMALE
18-42 years
Brief Summary
This study evaluates the immunomodulatory effects of subcutaneous progesterone in patients undergoing IVF by determination of anti-nuclear antibodies (ANA),extractable nuclear antigen antibodies (ENA)...
Detailed Description
The aqueous progesterone preparation for s.c. injection is the first systemic progesterone of its kind for the provision of luteal phase support (LPS) in patients undergoing IVF. The the high solubil...
Eligibility Criteria
Inclusion
- Infertile patients affected by autoimmune diseases undergoing IVF
Exclusion
- infertile patients without autoimmune diseases, fertile patients affected by autoimmune diseases
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04665232
Start Date
April 1 2014
End Date
April 1 2017
Last Update
May 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assunta Iuliano
Potenza, Italy, 85100